Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 87
Filter
Add more filters










Publication year range
1.
Peptides ; 132: 170350, 2020 10.
Article in English | MEDLINE | ID: mdl-32579899

ABSTRACT

Apelin has complex vasomotor actions inasmuch as the peptide may cause either vasodilation or vasoconstriction depending on the vascular bed and experimental conditions. In cerebral arteries, apelin inhibits endothelium-dependent relaxations mediated by nitric oxide (NO); however, its effects on relaxation to other endothelium-derived substances (e.g. prostacyclin, endothelium-derived hyperpolarizing factors(s) (EDHF)) are unknown. The present study was designed to determine effects of apelin on endothelium-dependent relaxations that are independent of NO in rat cerebral arteries. In arterial rings contracted with 5-HT, A23187 caused endothelium-dependent relaxation that was unaffected by inhibitors of eNOS, guanylyl cyclase or cyclooxygenase, but was attenuated by MS-PPOH, a selective inhibitor of cytochrome P450 catalyzed synthesis of epoxyeicosatrienoic acids (EETs) and by 14,15-EE(Z)E, an EET-receptor antagonist. Apelin inhibited A23187-induced relaxation, as well as relaxations evoked by exogenous 11,12- and 14,15-EET. These effects of apelin were mimicked by the selective BKCa channel blocker, iberiotoxin. The APJ receptor antagonist, F13A abolished the effects of apelin on A23187-induced relaxations. Both 11,12- and 14,15-EET also increased BKCa channel current density in isolated cerebral artery smooth muscle cells, effects that were inhibited in a similar manner by apelin and iberiotoxin. These findings provide evidence that apelin impairs endothelium-dependent relaxation of cerebral arteries by inhibiting an NO-independent pathway (i.e. "EDHF-like") involving activation of smooth muscle cell BKCa channels by endothelium-derived EETs. Inhibition of such pathway may create an environment favoring vasoconstriction in cerebral arteries.


Subject(s)
Apelin/pharmacology , Biological Factors/antagonists & inhibitors , Cerebral Arteries/drug effects , Endothelium, Vascular/drug effects , Potassium Channels, Calcium-Activated/metabolism , Animals , Biological Factors/metabolism , Cerebral Arteries/metabolism , Endothelium, Vascular/metabolism , Male , Models, Animal , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Vasoconstriction/drug effects , Vasodilation/drug effects
2.
Alcohol Clin Exp Res ; 42(4): 682-690, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29363778

ABSTRACT

BACKGROUND: A cardinal feature of fetal alcohol syndrome is growth restriction. Maternal uterine artery adaptations to pregnancy correlate with birthweight and survival. We hypothesized that gestational binge alcohol exposure impairs maternal uterine vascular function, affecting endothelial nitric oxide (NO)-mediated vasodilation. METHODS: Pregnant rats grouped as pair-fed control or binge alcohol exposed received a once-daily, orogastric gavage of isocaloric maltose-dextrin or alcohol, respectively. On gestational day 20, primary uterine arteries were isolated, cannulated, and connected to a pressure transducer, and functional studies were conducted by dual-chamber arteriography. Uterine arteries maintained at constant intramural pressure (90 mm Hg) were maximally constricted with thromboxane, and a dose-response for acetylcholine (Ach) was recorded. RESULTS: The alcohol group exhibited significantly impaired endothelium-dependent, Ach-induced uterine artery relaxation (↓∼30%). Subsequently, a dose-response was recorded following inhibition of endothelium-derived hyperpolarizing factor (apamin and TRAM-34) and prostacyclin (indomethacin). Ach-induced relaxation in the pair-fed control decreased by ~46%, and interestingly, relaxation in alcohol group further decreased by an additional ~48%, demonstrating that gestational binge alcohol impairs the NO system in the primary uterine artery. An endothelium-independent sodium nitroprusside effect was not observed. Immunoblotting indicated that alcohol decreased the level of endothelial excitatory P-Ser1177 endothelial NO synthase (eNOS) (p < 0.05) and total eNOS expression (p < 0.05) compared to both the normal and pair-fed controls. P-Ser1177 eNOS level was also confirmed by immunofluorescence imaging. CONCLUSIONS: This is the first study to demonstrate maternal binge alcohol consumption during pregnancy disrupts uterine artery vascular function via impairment of the eNOS vasodilatory system.


Subject(s)
Binge Drinking/physiopathology , Ethanol/toxicity , Nitric Oxide Synthase Type III/metabolism , Uterine Artery/physiopathology , Vasodilation/physiology , Acetylcholine/pharmacology , Animals , Apamin/pharmacology , Biological Factors/antagonists & inhibitors , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Epoprostenol/pharmacology , Female , Nitroprusside/pharmacology , Pregnancy , Pyrazoles/pharmacology , Rats , Uterine Artery/drug effects , Vasodilation/drug effects
3.
Biol Pharm Bull ; 39(3): 384-93, 2016.
Article in English | MEDLINE | ID: mdl-26934930

ABSTRACT

We investigated the relationship between noradrenaline (NAd)-induced contractions, endothelial function, and hypertension in femoral arteries isolated from spontaneously hypertensive rats (SHR). In the femoral arteries of SHR, vs. age-matched control Wistar Kyoto (WKY) rats, contractions induced by NAd were increased. These effects were enhanced by endothelial denudation, which abolished the differences between the two groups. NAd-induced contractions were enhanced by nitric oxide (NO) synthase inhibition, and further increased by the blockade of endothelium-derived hyperpolarizing factor (EDHF). Conversely, NAd-induced contractions were inhibited by cyclooxygenase (COX) inhibition. In addition, in SHR arteries, acetylcholine-induced relaxation was reduced, and components of endothelium-derived factors were altered, such as increased COX-derived vasoconstrictor prostanoids, reduced EDHF, and preserved NO-mediated relaxation. In the femoral arteries of SHR, the production of prostanoids [6-keto prostaglandin (PG)F1α (a metabolite of prostacyclin (PGI2), PGE2, and PGF2α] and COX-2 protein were increased compared with that in WKY rats. By contrast, contractions induced by beraprost (a stable PGI2 analogue), PGE2, and U46619 (thromboxane/prostanoid receptor agonist) were similar between the SHR and WKY groups. Thus, NAd-induced femoral arterial contractions are augmented in SHR resulting from endothelial dysfunction and increased COX-derived vasoconstrictor prostanoid levels.


Subject(s)
Femoral Artery/physiopathology , Hypertension/physiopathology , Norepinephrine , Vasoconstriction/physiology , Acetylcholine , Animals , Biological Factors/antagonists & inhibitors , Cyclooxygenase Inhibitors/pharmacology , Endothelium, Vascular/physiology , Femoral Artery/metabolism , Femoral Artery/physiology , Hypertension/metabolism , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Prostaglandins/metabolism , Rats, Inbred SHR , Rats, Inbred WKY , Vasoconstriction/drug effects , Vasoconstrictor Agents
4.
Biol Reprod ; 89(4): 97, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23966325

ABSTRACT

Prenatal testosterone (T) exposure impacts postnatal cardiovascular function, leading to increases in blood pressure with associated decreased endothelium-dependent vascular relaxation in adult females. Endothelial function in males is not known. Furthermore, which of the endothelial pathways contributes to endothelial dysfunction and if there exists sex differences are not known. The objective of this study was to characterize the relative contribution of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) to the impaired endothelium-dependent vasodilation in prenatal T-exposed adult males and females. Offspring of pregnant rats treated with T propionate or its vehicle were examined. Telemetric blood pressure levels and endothelium-dependent vascular reactivity were assessed with wire myography. Levels of nitric oxide synthase (NOS3) and Kcnn3 and Kcnn4 channel expression were examined in mesenteric arteries. Mean arterial pressure was significantly higher in T males and females than in controls. Endothelium-dependent acetylcholine relaxation was significantly lower in both T males and females. EDHF-mediated relaxation was specifically blunted in T males (Emax = 48.64% ± 3.73%) compared to that in control males (Emax = 81.71% ± 3.18%); however, NO-mediated relaxation was specifically impaired in T females (Emax = 36.01% ± 4.29%) compared with that in control females (Emax = 54.56% ± 6.37%). Relaxation to sodium nitroprusside and levcromakalim were unaffected with T-treatment. NOS3 protein was decreased in T females but not in T males. Kcnn3 expression was decreased in both T males and females compared to controls. These findings suggest that prenatal T leads to an increase in blood pressure in the adult offspring, associated with blunting of endothelial cell-associated relaxation and that the effects are sex-specific: EDHF-related in males and NO-related in females.


Subject(s)
Androgens/adverse effects , Endothelium, Vascular/drug effects , Hypertension/chemically induced , Nitric Oxide Synthase Type III/metabolism , Prenatal Exposure Delayed Effects , Small-Conductance Calcium-Activated Potassium Channels/metabolism , Testosterone/adverse effects , Androgens/blood , Animals , Biological Factors/antagonists & inhibitors , Biological Factors/metabolism , Down-Regulation/drug effects , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Female , Fetal Development/drug effects , Hypertension/metabolism , Hypertension/physiopathology , Intermediate-Conductance Calcium-Activated Potassium Channels/genetics , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/metabolism , Mesenteric Arteries/physiopathology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Nitric Oxide Synthase Type III/antagonists & inhibitors , Pregnancy , Rats , Rats, Sprague-Dawley , Sex Characteristics , Small-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Small-Conductance Calcium-Activated Potassium Channels/genetics , Testosterone/blood , Testosterone Propionate/administration & dosage , Vasodilation/drug effects
5.
Int Angiol ; 32(3): 312-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23711683

ABSTRACT

AIM: Acetylcholine (ACh) is an endothelium-dependent vasodilator used to investigate endothelial function in the microcirculation. The mediators of its vasodilatory effects are not clear, but endothelium-derived hyperpolarising factor (EDHF) is thought to contribute, and appears to have particular importance in smaller peripheral vessels. The aim of this study was to investigate the role of EDHF in ACh-mediated vasodilator responses in human forearm skin. METHODS: Laser Doppler imaging was used to measure forearm skin blood flow responses to iontophoretic administration of ACh in 7 healthy men. ACh in a 10-mg/mL solution was administered in accumulating doses using increasing delivery currents of 10, 15, 20, 50 and 100 µA. The measurements were repeated on subsequent visits when the effects of EDHF were blocked using intra-arterial sulphaphenazole at 2 mg/min (a cytochrome P-450 inhibitor), nitric oxide (NO) was blocked using intra-arterial administration of the NO synthetase inhibitor l-NG-monomethyl arginine (l-NMMA) at 4 µmol/min, and prostanoids were blocked with oral aspirin 1 g. RESULTS: The microvascular response to ACh was significantly attenuated by sulphaphenazole alone (P=0.018), l-NMMA alone (P<0.001) and the combination of sulphaphenazole plus l-NMMA (P<0.001), and aspirin had no additional effect. CONCLUSION: EDHF is a significant contributor to the vasodilatory effects of ACh in the human dermal microcirculation. Information about abnormalities in specific pathways of endothelial function in patient groups may help in the targeting of appropriate drug therapies.


Subject(s)
Acetylcholine/administration & dosage , Biological Factors/metabolism , Microvessels/drug effects , Skin/blood supply , Vasodilation/drug effects , Vasodilator Agents/administration & dosage , Administration, Cutaneous , Adult , Biological Factors/antagonists & inhibitors , Blood Flow Velocity , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/administration & dosage , Healthy Volunteers , Humans , Iontophoresis , Laser-Doppler Flowmetry , Male , Microcirculation/drug effects , Microvessels/metabolism , Middle Aged , Nitric Oxide/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Prostaglandins/metabolism , Regional Blood Flow , Young Adult
6.
Yao Xue Xue Bao ; 48(11): 1657-64, 2013 Nov.
Article in Chinese | MEDLINE | ID: mdl-24475702

ABSTRACT

This study is to investigate the impairment and possible mechanism of endothelium-dependent relaxation of mice mesenteric arteries induced by mmLDL. Wire myography was employed to examine endothelial function of mesenteric arteries. Ultramicrostructure of mesenteric vascular beds were detected by transmission electron microscope. The results showed that endothelium cell edema and peeling, vascular elastic membrane fracture traces in mmLDL group. Endothelium-dependent relaxation was decreased in a time-dependent and dose-dependent manner by using mmLDL, compared with normal arteries. In endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation, the Rmax and pIC50 were decreased from (63 +/- 5) % and 6.42 +/- 0.09 of normal saline control to (31 +/- 3) % and 5.67 +/- 0.07 in mmLDL group (P < 0.001, P < 0.001), respectively. In nitric oxide (NO)-mediated relaxation, the Rmax and pIC50 were decreased from (45 +/- 4) % and 5.93 +/- 0.08 in normal saline control to (32 +/- 4) % and 5.43 +/- 0.11 in mmLDL group (P < 0.05, P < 0.01), respectively. There is no significant alteration of prostacyclin I2 (PGI2) pathway between these two groups. In conclusion, mmLDL induced the impairment of the ultramicrostructure of mesenteric vascular endothelium cell as well as the endothelium-dependent relaxation. The latter includes the dysfunction of NO- and EDHF pathway mediated endothelium-dependent relaxation.


Subject(s)
Lipoproteins, LDL/pharmacology , Mesenteric Arteries/physiology , Vasodilation/drug effects , Animals , Biological Factors/antagonists & inhibitors , Biological Factors/physiology , Dose-Response Relationship, Drug , Endothelial Cells/drug effects , Endothelial Cells/ultrastructure , Epoprostenol/antagonists & inhibitors , Epoprostenol/physiology , Female , Lipoproteins, LDL/administration & dosage , Male , Mesenteric Arteries/cytology , Mesenteric Arteries/ultrastructure , Mice , Mice, Inbred ICR , Microscopy, Electron, Transmission , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/physiology
7.
Biol Reprod ; 83(5): 728-35, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20610807

ABSTRACT

This ex vivo study focuses on the mechanisms of endothelium-dependent dilatation in the uterine circulation of normal pregnancy (n = 12) and in women with preeclampsia (n = 12). Arteries (internal diameter, ∼250 µm) isolated by myometrial biopsy from women undergoing planned cesarean delivery or delivery as a result of the deterioration of preeclampsia were studied using a wire myograph. Bradykinin-induced dilatation was assessed in the presence and/or absence of pharmacological inhibitors to determine the contribution of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF), as well as that of EDHF-mediated pathways such as myoendothelial gap junctions (MEGJs) and products of arachidonic acid, H(2)O(2) and cytochrome P450 2C9 (CYP2C9). Transmission electron microscopy was used to visualize morphological prerequisites for MEGJs. In normal pregnancy, EDHF through MEGJs appeared to be a predominant mediator conferring endothelium-dependent relaxation in small myometrial arteries. In preeclampsia, bradykinin-induced relaxation was reduced via compromised EDHF-type responses, in which the contribution of MEGJs became negligible. The attenuated role of MEGJs to endothelium-dependent relaxation was partly compensated through the contribution of H(2)O(2) or other endothelium-derived relaxing factors. CYP2C9 products of arachidonic acid had no effect on EDHF-type relaxation in arteries of women with normal pregnancy or with preeclampsia. We suggest that EDHF-type responses via MEGJs are primarily targeted in small myometrial arteries in women with preeclampsia. This could significantly contribute to the impaired uteroplacental blood flow in this disorder.


Subject(s)
Arteries/physiopathology , Biological Factors/physiology , Myometrium/blood supply , Pre-Eclampsia/physiopathology , Vasodilation/drug effects , Adult , Arteries/drug effects , Biological Factors/antagonists & inhibitors , Bradykinin/antagonists & inhibitors , Bradykinin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Endothelium, Vascular/ultrastructure , Female , Gap Junctions/drug effects , Gap Junctions/physiology , Gap Junctions/ultrastructure , Humans , In Vitro Techniques , Microscopy, Electron, Transmission , Nitric Oxide Synthase/antagonists & inhibitors , Osmolar Concentration , Pregnancy , Vascular Resistance/drug effects , Vascular Resistance/physiology , Vasodilator Agents/antagonists & inhibitors , Vasodilator Agents/pharmacology , Young Adult
9.
J Cardiovasc Pharmacol ; 54(6): 526-34, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19755915

ABSTRACT

Sepsis has been reported to impair endothelium-dependent vasodilations mediated by nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). Although some studies demonstrate that statins can improve NO-mediated response in septic animals, little is known about its effect on the EDHF response. The present study examined the effects of atorvastatin pretreatment on sepsis-induced endothelial dysfunctions and hypotension in rats. Eighteen hours after the induction of sepsis by cecal ligation and puncture, thoracic aorta and second generation pulmonary arteries were isolated to examine acetylcholine-induced endothelium-dependent dilations mediated by NO and EDHF, respectively. The messenger RNA (mRNA) expression for endothelial NO synthase (eNOS) and inducible NO synthase (iNOS) was done by real-time polymerase chain reaction. NO was measured as nitrate/nitrite release using Griess method. Mean arterial pressure was measured by the invasive method. Sepsis significantly decreased (26%) the relaxation response to acetylcholine in the rat aorta. It also markedly inhibited the eNOS mRNA expression and acetylcholine-stimulated NO release in this vessel. Pretreatment of the rats with atorvastatin (10 mg/kg, orally) 48, 24, and 2 hours before induction of sepsis preserved acetylcholine-induced relaxation, eNOS mRNA expression, acetylcholine-stimulated NO release, and attenuated increase in the inducible NO synthase mRNA expression and basal NO production in the aorta. The maximal EDHF response mediated by acetylcholine was 25.30% +/- 3.00% in the pulmonary artery. Sepsis abolished this response but atorvastatin restored it (22.55% +/- 2.50%). Atorvastatin, however, failed to prevent sepsis-induced hypotension. These results suggest that atorvastatin can restore impaired endothelium-dependent vasodilations mediated by NO and EDHF but not hypotension in sepsis.


Subject(s)
Biological Factors/metabolism , Endothelium, Vascular/physiopathology , Heptanoic Acids/pharmacology , Hypotension/physiopathology , Nitric Oxide/metabolism , Pyrroles/pharmacology , Sepsis/prevention & control , Vasodilation/drug effects , Acetylcholine/pharmacology , Animals , Aorta/drug effects , Aorta/metabolism , Aorta/physiopathology , Atorvastatin , Biological Factors/antagonists & inhibitors , Blood Cell Count , Blood Pressure/drug effects , Blood Pressure/physiology , Calcium Channel Blockers/pharmacology , Cytochrome P-450 Enzyme Inhibitors , Disease Models, Animal , Endothelium, Vascular/drug effects , Gene Expression/drug effects , Gene Expression/genetics , Heptanoic Acids/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypotension/etiology , Hypotension/prevention & control , Indomethacin/pharmacology , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/antagonists & inhibitors , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/genetics , Nitrites/blood , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Pulmonary Artery/drug effects , Pulmonary Artery/metabolism , Pulmonary Artery/physiopathology , Pyrroles/therapeutic use , Rats , Rats, Wistar , Sepsis/blood , Sepsis/complications , Sepsis/physiopathology , Vasodilation/physiology
10.
Vascul Pharmacol ; 51(2-3): 154-61, 2009.
Article in English | MEDLINE | ID: mdl-19520187

ABSTRACT

The previously documented impairment of hindlimb blood flow consecutive to chronic hypoxia might be related to endothelial vasomotor dysfunction. The aim of this study was to assess in-vivo the effect of chronic hypoxic stress on endothelium-mediated vasodilator response of hindlimb vascular bed, especially as regards to endothelium-derived hyperpolarizing factor (EDHF) and nitric oxide (NO) pathway contribution. Dark Agouti rats were randomly assigned to live at barometric pressure approximately 760 mmHg (N rats) or approximately 550 mmHg (CH rats). Under anesthesia, catheters were placed in the carotid artery for arterial pressure measurement, and in the saphenous vein and iliac artery for drug delivery. Hindlimb blood flow (HBF) was measured by transit-time ultrasound flowmetry, at baseline and during endothelium-dependent vasodilator response induced by intra-arterial injection of acetylcholine (0.75 ng and 7.5 ng) with and without specific blockers of NOS (L-NAME) and EDHF (Charybdotoxin+Apamin). HBF and hindlimb vascular conductance changes in response to ACh infusion were significantly lower in CH than in N rats. The mechanisms responsible for this blunted response involved impairment in both NO pathway and EDHF. The chronic hypoxia-induced alteration of NO pathway was mainly related to the bioavailability of its substrate l-Arginine, since the infusion of l-Arginine restored the endothelial response to ACh in CH rats to the level of N rats. These results demonstrate that the impairment in endothelium-mediated vasodilator response of the hindlimb vascular tree induced by chronic hypoxic stress involves both NO and EDHF.


Subject(s)
Biological Factors/physiology , Endothelium, Vascular/physiology , Nitric Oxide/physiology , Oxygen/physiology , Stress, Physiological , Vasodilation/physiology , Acetylcholine/physiology , Animals , Arginine/physiology , Atmosphere Exposure Chambers , Biological Factors/antagonists & inhibitors , Blood Pressure , Diet , Hindlimb/blood supply , Infusions, Intravenous , Male , Nitric Oxide Synthase/antagonists & inhibitors , Random Allocation , Rats , Regional Blood Flow , Time Factors
11.
J Pharmacol Exp Ther ; 328(2): 478-86, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18984652

ABSTRACT

Hypertension has been shown to be associated with impaired endothelium-derived hyperpolarizing factor (EDHF)-mediated arterial relaxation and hyperpolarization. Treatments of hypertensive rats with inhibitors of the renin-angiotensin system have been shown to restore both EDHF-mediated responses and the expression of connexins involved in the intercellular transfer of the hyperpolarization in mesenteric arteries. The present study was designed to determine whether chronic treatment of rats with angiotensin II impairs EDHF-mediated responses and the expression of connexins in the mesenteric arterial wall. Male Wistar rats were treated with angiotensin II (0.4 mg/kg/day) for 21 days using osmotic minipumps. Arterial pressure was measured by tail-cuff plethysmography. Contractile responses and membrane potential were measured in isolated mesenteric arteries. The expression of the three connexins (Cxs), Cx37, Cx40, and Cx43, was quantified in segments of mesenteric arteries by immunohistochemistry and quantitative real-time reverse transcriptase-polymerase chain reaction. Angiotensin II administration increased the mean systolic blood pressure. EDHF-mediated relaxation and hyperpolarization to acetylcholine and red wine polyphenols were significantly impaired in mesenteric arteries from angiotensin II-treated rats in comparison with control animals, whereas nitric oxide-mediated relaxation was unaltered. The expression of connexins Cx37, Cx40, and Cx43 was significantly decreased in the mesenteric artery from angiotensin II-treated rats. These findings indicate that angiotensin II-induced hypertension is associated with a selective impairment of EDHF-mediated relaxation and hyperpolarization in the rat mesenteric artery. The inhibition of EDHF-mediated responses is due, at least in part, to a decreased expression of connexins Cx37, Cx40, and Cx43 in the arterial wall.


Subject(s)
Angiotensin II/pharmacology , Biological Factors/antagonists & inhibitors , Blood Pressure/physiology , Hypertension/physiopathology , Mesenteric Arteries/drug effects , Acetylcholine/pharmacology , Animals , Biological Factors/genetics , Biological Factors/physiology , Blood Pressure/drug effects , Hypertension/chemically induced , Male , Mesenteric Arteries/metabolism , Mesenteric Arteries/physiopathology , Muscle Relaxation/drug effects , Rats , Rats, Wistar
12.
Am J Physiol Heart Circ Physiol ; 292(6): H2737-44, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17220192

ABSTRACT

Pulmonary hypertension (PH) causes right ventricular (RV) hypertrophy and, according to the extent of pressure overload, eventual heart failure. We tested the hypothesis that the mechanical stress in PH-RV impairs the vasoreactivity of the RV coronary microvessels of different sizes with increased superoxide levels. Five-week-old male Sprague-Dawley rats were injected with monocrotaline (n=126) to induce PH or with saline as controls (n=114). After 3 wk, coronary arterioles (diameter = 30-100 microm) and small arteries (diameter = 100-200 microm) in the RV were visualized using intravital videomicroscopy. We evaluated ACh-induced vasodilation alone, in the presence of N(omega)-nitro-L-arginine methyl ester (L-NAME), in the presence of tetraethylammonium (TEA) or catalase with or without L-NAME, and in the presence of SOD. The degree of suppression in vasodilation by L-NAME and TEA was used as indexes of the contributions of endothelial nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF), respectively. In PH rats, ACh-induced vasodilation was significantly attenuated in both arterioles and small arteries, especially in arterioles. This decreased vasodilation was largely attributable to reduced NO-mediated vasoreactivity, whereas the EDHF-mediated vasodilation was relatively robust. The suppressive effect on arteriolar vasodilation by catalase was similar to TEA in both groups. Superoxide, as measured by lucigenin chemiluminescence, was significantly elevated in the RV tissues in PH. SOD significantly ameliorated the impairment of ACh-induced vasodilation in PH. Robust EDHF function will play a protective role in preserving coronary microvascular homeostasis in the event of NO dysfunction with increased superoxide levels.


Subject(s)
Biological Factors/metabolism , Coronary Circulation , Coronary Vessels/metabolism , Hypertension, Pulmonary/metabolism , Hypertrophy, Right Ventricular/metabolism , Nitric Oxide/metabolism , Superoxides/metabolism , Vasodilation , Acetylcholine/pharmacology , Animals , Biological Factors/antagonists & inhibitors , Catalase/metabolism , Coronary Circulation/drug effects , Coronary Vessels/drug effects , Coronary Vessels/pathology , Coronary Vessels/physiopathology , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , Hypertension, Pulmonary/chemically induced , Hypertension, Pulmonary/complications , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Hypertrophy, Right Ventricular/etiology , Hypertrophy, Right Ventricular/pathology , Hypertrophy, Right Ventricular/physiopathology , Male , Microcirculation/metabolism , Microcirculation/physiopathology , Microscopy, Video , Monocrotaline , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitroprusside/pharmacology , Potassium Channel Blockers/pharmacology , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Tetraethylammonium/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology
13.
Eur J Pharmacol ; 546(1-3): 120-6, 2006 Sep 28.
Article in English | MEDLINE | ID: mdl-16876156

ABSTRACT

Several in vitro studies have shown that endothelium-dependent vasodilatation is maintained by endothelium-derived hyperpolarizing factor (EDHF) or prostacyclin in vessels isolated from endothelial nitric oxide synthase knockout mice. Since this has not been addressed by in vivo studies, we sought to define the magnitude and the onset time of this compensation by recording blood pressure responses to endothelium-dependent vasodilators in rats treated acutely or chronically with the NOS inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME). Groups of male Sprague-Dawley rats were given plain water (control) or L-NAME (0.7 mg/ml) in drinking water for 1 day, 5 days, 3 wks or 6 wks. Dose-dependent hypotensive responses to acetylcholine, bradykinin and sodium nitroprusside were determined in anesthetized rats before and after acute intravenous infusion of either L-NAME or a combination of apamin plus charybdotoxin that would selectively inhibit EDHF. Acute L-NAME treatment increased the mean arterial pressure and inhibited acetylcholine- and bradykinin-induced fall in blood pressure in control but not in chronic L-NAME treated rats. The endothelium-dependent hypotensive responses to acetylcholine and bradykinin were restored in rats treated with L-NAME after a time period of 24 h along with increased sensitivity to sodium nitroprusside and reduced plasma nitrate+nitrite levels. While apamin+charybdotoxin pretreatment inhibited the responses to acetylcholine and bradykinin in both acute and chronic L-NAME treated groups, it was more pronounced in the latter group. In conclusion, chronic inhibition of nitric oxide synthase results in the development of a compensatory hypotensive response to acetylcholine within 24 h and this is mediated by EDHF.


Subject(s)
Acetylcholine/pharmacology , Biological Factors/metabolism , Hypotension/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Vasodilator Agents/pharmacology , Animals , Apamin/pharmacology , Biological Factors/antagonists & inhibitors , Blood Pressure/drug effects , Bradykinin/pharmacology , Charybdotoxin/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Enzyme Inhibitors/pharmacology , Hypotension/physiopathology , Male , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/metabolism , Nitroglycerin/pharmacology , Nitroprusside/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels, Calcium-Activated/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Time Factors
14.
Eur J Pharmacol ; 534(1-3): 152-8, 2006 Mar 18.
Article in English | MEDLINE | ID: mdl-16612841

ABSTRACT

Ascorbate blocks agonist-induced, endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine perfused ciliary artery and this is associated with a rise in perfusion pressure. We now report the origins of this ascorbate-induced rise in perfusion pressure. In segments of ciliary artery perfused at 2.5 ml/min, the addition of ascorbate (10-150 microM) enhanced U46619-induced perfusion pressure. Ascorbate produced no enhancement in the absence of U46619, suggesting that its effects resulted not from a constrictor action but through removal of a tonic vasodilator influence. Experiments revealed the endothelial source of this vasodilator influence, and EDHF, but not nitric oxide or prostanoids, appeared to be involved. The ascorbate-induced enhancement of vasoconstrictor tone was not seen in a static myograph or in segments perfused at low rates of flow, but was seen at flow rates of 2.5 ml(-1) and above. We conclude that ascorbate augments vasoconstrictor tone through inhibition of flow-induced EDHF activity.


Subject(s)
Ascorbic Acid/pharmacology , Biological Factors/antagonists & inhibitors , Ciliary Arteries/drug effects , Vasodilation , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology , Animals , Biological Factors/metabolism , Cattle , Ciliary Arteries/metabolism , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Intermediate-Conductance Calcium-Activated Potassium Channels/drug effects , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , Perfusion , Potassium Channel Blockers/pharmacology , Pressure , Pyrazoles/pharmacology , Vasoconstrictor Agents/pharmacology
15.
J Pharmacol Exp Ther ; 318(1): 276-81, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16565165

ABSTRACT

Individual vascular beds exhibit differences in vascular reactivity. The present study investigates the effects of streptozotocin-induced type I diabetes on endothelium-dependent responses of rat carotid, femoral, and mesenteric arteries. Rings with and without endothelium, suspended in organ chambers for isometric tension recording, were contracted with phenylephrine and exposed to increasing concentrations of acetylcholine. In carotid and femoral arteries, acetylcholine produced concentration- and endothelium-dependent relaxations that were abolished by Nomega-nitro-L-arginine methyl ester (L-NAME; specific nitric-oxide synthase inhibitor) and were impaired slightly in preparations from streptozotocin-treated rats (STZ-rats). This impairment could be prevented by L-arginine. In femoral arteries incubated with L-NAME, acetylcholine caused endothelium-dependent contractions that were abolished by 3-[(6-amino-(4-chlorobenzensulfonyl)-2-methyl-5,6,7,8-tetrahydronapht]-1-yl) propionic acid (S18886) (antagonist of thromboxane A2/prostaglandins H2-receptors) and reversed to relaxation by indomethacin (inhibitor of cyclooxygenase). The latter relaxation was inhibited by charybdotoxin plus apamin, suggesting a role of endothelium-dependent hyperpolarizing factor (EDHF). This EDHF-mediated component was augmented slightly in arteries from STZ-rats. In mesenteric arteries, relaxations to acetylcholine were only partially inhibited by L-NAME, and the L-NAME-resistant component was abolished by charybdotoxin plus apamin. In the mesenteric arteries from STZ-rats, L-NAME-sensitive relaxations to acetylcholine were reduced and the EDHF-component was augmented. These findings demonstrate a marked heterogeneity in endothelium-dependent responses in rat arteries and their differential adaptation in the course of type I diabetes. In particular, the EDHF-mediated component not only compensates for the reduced bioavailability of nitric oxide in the femoral and mesenteric artery but also counteracts the augmented endothelium-dependent contractions in the former.


Subject(s)
Biological Factors/physiology , Carotid Arteries/physiology , Diabetes Mellitus, Type 1/physiopathology , Femoral Artery/physiology , Mesenteric Arteries/physiology , Vasodilation/physiology , Acetylcholine/pharmacology , Animals , Biological Factors/antagonists & inhibitors , Carotid Arteries/drug effects , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 1/chemically induced , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Femoral Artery/drug effects , Male , Mesenteric Arteries/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Rats , Rats, Sprague-Dawley , Vascular Diseases/physiopathology , Vasodilation/drug effects
16.
BMC Cardiovasc Disord ; 6: 3, 2006 Jan 19.
Article in English | MEDLINE | ID: mdl-16423279

ABSTRACT

BACKGROUND: Cigarette smoking is a strong risk factor for vascular disease and known to cause dysfunction of the endothelium. However, the molecular mechanisms involved are still not fully understood. METHODS: In order to reveal the direct effects of lipid-soluble smoke particles on the endothelium, ring segments isolated from rat mesenteric arteries and human middle cerebral arteries (MCA) obtained at autopsy were incubated for 6 to 48 hrs in the presence of dimethylsulphoxide (DMSO)-soluble particles from cigarette smoke (DSP), i.e. lipid-soluble smoke particles. The endothelial microstructure was examined by transmission electron microscopy. The endothelial function was evaluated by acetylcholine (ACh)-induced endothelium-dependent vasodilatation, using a sensitive myograph. RESULTS: After DSP treatment, the arterial endothelium was swollen and loosing its attachment. In functional tests, the total ACh-induced dilatation, the nitric oxide (NO)-mediated and the endothelium-derived hyperpolarization factor (EDHF)-mediated dilatations were significantly decreased by DSP in a time- and concentration-dependent manner (p < 0.05). Nicotine, an important compound in cigarette smoke had, in an equivalent concentration as in DSP, no such effects (p > 0.05). Similar results were obtained in the human MCA. CONCLUSION: Thus, we demonstrate that the lipid-soluble smoke particles, but not nicotine, caused damage to arterial endothelium and reduced the endothelium-dependent dilatation in man and rat.


Subject(s)
Endothelium, Vascular/drug effects , Lipids/analysis , Nicotiana/toxicity , Smoke/analysis , Vasodilation , Animals , Biological Factors/antagonists & inhibitors , Biological Factors/metabolism , Dimethyl Sulfoxide/chemistry , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Endothelium, Vascular/ultrastructure , Female , Humans , In Vitro Techniques , Lipids/chemistry , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/metabolism , Mesenteric Arteries/ultrastructure , Middle Cerebral Artery/drug effects , Middle Cerebral Artery/metabolism , Middle Cerebral Artery/ultrastructure , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Rats , Rats, Sprague-Dawley , Solubility , Time Factors , Nicotiana/chemistry
17.
Ann Thorac Surg ; 80(5): 1803-11, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16242459

ABSTRACT

BACKGROUND: We investigated effects of hypoxia-reoxygenation (H-R) with and without St. Thomas solution under clinically relevant temperatures and effects of nicorandil on endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation in porcine coronary microarteries. METHODS: In a myograph, rings of porcine microarteries (diameter 200 to 450 microm) were subjected to hypoxia (PO2 < 5 mm Hg) for 30 minutes in Krebs at 37 degrees C, or for 60 minutes in Krebs and St. Thomas solution with or without nicorandil (0.1 microM) at 37 degrees C or 4 degrees C, followed by 30-minute reoxygenation. The EDHF-mediated relaxation by bradykinin (-10 to approximately -6 logM) with inhibitors of nitric oxide and prostacyclin was studied. RESULTS: The maximal EDHF-mediated relaxation was reduced after hypoxia for 30 minutes (59.9%% +/- 1.6% versus 81.2%% +/- 3.5%, p < 0.05) or 60 minutes (44.4% +/- 6.0% versus 82.7% +/- 7.4%, p < 0.001) in Krebs or St. Thomas (28.9% +/- 1.8% versus 78.1% +/- 3.0%, p < 0.001) at 37 degrees C and at 4 degrees C (Krebs: 49.3% +/- 3.0%, p < 0.001; ST: 43.1% +/- 2.6%, p < 0.001) and it was less in St. Thomas solution at 37 degrees C than at 4 degrees C (p < 0.001). The reduced relaxation was recovered by nicorandil (Krebs at 37 degrees C: 81.7% +/- 3.4%, p < 0.001; St. Thomas at 37 degrees C: 71.0% +/- 7.9%, p <0.001; St. Thomas at 4 degrees C: 85.3% +/- 3.3%, p < 0.001). CONCLUSIONS: We conclude that (1) H-R impairs EDHF-mediated relaxation in the coronary microarteries with more injury during prolonged H-R, and this can be partially eliminated by St. Thomas at 4 degrees C but not at 37 degrees C; and (2) as an additive, nicorandil may fully restore EDHF-mediated endothelial function after prolonged H-R.


Subject(s)
Biological Factors/antagonists & inhibitors , Muscle, Smooth, Vascular/drug effects , Nicorandil/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Animals , Bicarbonates/pharmacology , Calcium Chloride/pharmacology , Cell Hypoxia/drug effects , Drug Interactions , Magnesium/pharmacology , Potassium Chloride/pharmacology , Sodium Chloride/pharmacology , Swine
18.
Nature ; 437(7059): 750-3, 2005 Sep 29.
Article in English | MEDLINE | ID: mdl-16193054

ABSTRACT

Bacteria communicate by means of chemical signal molecules called autoinducers. This process, called quorum sensing, allows bacteria to count the members in the community and to alter gene expression synchronously across the population. Quorum-sensing-controlled processes are often crucial for successful bacterial--host relationships--both symbiotic and pathogenic. Most quorum-sensing autoinducers promote intraspecies communication, but one autoinducer, called AI-2, is produced and detected by a wide variety of bacteria and is proposed to allow interspecies communication. Here we show that some species of bacteria can manipulate AI-2 signalling and interfere with other species' ability to assess and respond correctly to changes in cell population density. AI-2 signalling, and the interference with it, could have important ramifications for eukaryotes in the maintenance of normal microflora and in protection from pathogenic bacteria.


Subject(s)
Bacteria/cytology , Bacteria/metabolism , Homoserine/analogs & derivatives , Lactones/antagonists & inhibitors , Lactones/metabolism , Signal Transduction , Bacteria/genetics , Bacteria/pathogenicity , Biological Factors/antagonists & inhibitors , Biological Factors/metabolism , Coculture Techniques , Escherichia coli/cytology , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Homoserine/antagonists & inhibitors , Homoserine/metabolism , Peptide Hydrolases/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Vibrio/cytology , Vibrio/enzymology , Vibrio/metabolism , Vibrio/pathogenicity
19.
Circ Res ; 97(4): 399-407, 2005 Aug 19.
Article in English | MEDLINE | ID: mdl-16037574

ABSTRACT

In resistance arteries, spread of hyperpolarization from the endothelium to the adjacent smooth muscle is suggested to be a crucial component of dilation resulting from endothelium-derived hyperpolarizing factor (EDHF). To probe the role of endothelial gap junctions in EDHF-mediated dilation, we developed a method, which was originally used to load membrane impermeant molecules into cells in culture, to load connexin (Cx)-specific inhibitory molecules rapidly (approximately 15 minutes) into endothelial cells within isolated, pressurized mesenteric arteries of the rat. Validation was achieved by luminally loading cell-impermeant fluorescent dyes selectively into virtually all the arterial endothelial cells, without affecting either tissue morphology or function. The endothelial monolayer served as an effective barrier, preventing macromolecules from entering the underlying smooth muscle cells. Using this technique, endothelial cell loading either with antibodies to the intracellular carboxyl-terminal region of Cx40 (residues 340 to 358) or mimetic peptide for the cytoplasmic loop (Cx40; residues 130 to 140) each markedly depressed EDHF-mediated dilation. In contrast, multiple antibodies directed against different intracellular regions of Cx37 and Cx43, and mimetic peptide for the intracellular loop region of Cx37, were each without effect. Furthermore, simultaneous intra- and extraluminal incubation of pressurized arteries with inhibitory peptides targeted against extracellular regions of endothelial cell Cxs (43Gap 26, 40Gap 27, and (37,43)Gap 27; 300 micromol/L each) for 2 hours also failed to modify the EDHF response. High-resolution immunohistochemistry localized Cx40 to the end of endothelial cell projections at myoendothelial gap junctions. These data directly demonstrate a critical role for Cx40 in EDHF-mediated dilation of rat mesenteric arteries.


Subject(s)
Biological Factors/physiology , Connexins/physiology , Endothelial Cells/physiology , Mesenteric Arteries/physiology , Vasodilation , Acetylcholine/pharmacology , Animals , Biological Factors/antagonists & inhibitors , Calcium/metabolism , Carbenoxolone/pharmacology , Connexins/analysis , Hypertonic Solutions/pharmacology , Male , Osmolar Concentration , Potassium/metabolism , Rats , Rats, Wistar , Gap Junction alpha-5 Protein , Gap Junction alpha-4 Protein
20.
Br J Pharmacol ; 144(4): 576-87, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15655499

ABSTRACT

1. Mechanisms regulating coronary tone under basal conditions and during reactive hyperaemia following transient ischaemia were assessed in isolated mouse hearts. 2. Blockade of NO-synthase (50 muM L-NAME), K(ATP) channels (5 muM glibenclamide), A(2A) adenosine receptors (A(2A)ARs; 100 nM SCH58261), prostanoid synthesis (100 muM indomethacin), and EDHF (100 nM apamin+100 nM charybdotoxin) all reduced basal flow approximately 40%. Effects of L-NAME, glibenclamide, and apamin+charybdotoxin were additive, whereas coadministration of SCH58261 and indomethacin with these inhibitors failed to further limit flow. 3. Substantial hyperaemia was observed after 5-40 s occlusions, with flow increasing to a peak of 48+/-1 ml min(-1) g(-1). Glibenclamide most effectively inhibited peak flows (up to 50%) while L-NAME was ineffective. 4. With longer occlusions (20-40 s), glibenclamide alone was increasingly ineffective, reducing peak flows by approximately 15% after 20 s occlusion, and not altering peak flow after 40 s occlusion. However, cotreatment with L-NAME+glibenclamide inhibited peak hyperaemia by 70 and 25% following 20 and 40 s occlusions, respectively. 5. In contrast to peak flow changes, sustained dilation and flow repayment over 60 s was almost entirely K(ATP) channel and NO dependent (each contributing equally) with all occlusion durations. 6. Antagonism of A(2A)ARs with SCH58261 reduced hyperaemia 20-30% whereas inhibition of prostanoid synthesis was ineffective. Effects of A(2A)AR antagonism were absent in hearts treated with L-NAME and glibenclamide, supporting NO and K(ATP)-channel-dependent effects of A(2A)ARs. 7. EDHF inhibition alone exerted minor effects on hyperaemia and only with longer occlusions. However, residual hyperaemia after 40 s occlusion in hearts treated with L-NAME+glibenclamide+SCH58261+indomethacin was abrogated by cotreatment with apamin+charybdotoxin. 8. Data support a primary role for K(ATP) channels and NO in mediating sustained dilation after coronary occlusion. While K(ATP) channels (and not NO) are also important in mediating initial peak flow adjustments after brief 5-10 s occlusions, their contribution declines with longer 20-40 s occlusions. Intrinsic activation of A(2A)ARs is important in triggering K(ATP) channel/NO-dependent hyperaemia. Synergistic effects of combined inhibitors implicate interplay between mediators, with compensatory changes occurring in K(ATP) channel, NO, and/or EDHF responses when one is individually blocked.


Subject(s)
Biological Factors/antagonists & inhibitors , Coronary Vessels/metabolism , Heart/drug effects , Hyperemia/metabolism , Nitric Oxide/antagonists & inhibitors , Potassium Channels/metabolism , Adenosine Triphosphate/metabolism , Animals , Coronary Circulation/drug effects , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , NG-Nitroarginine Methyl Ester/pharmacology , Potassium Channel Blockers/pharmacology , Pyrimidines/pharmacology , Triazoles/pharmacology , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...